MedTrace Logo

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

NCT06544083 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-08-09

No results posted yet for this study

Summary

By collecting blood samples from liver cancer patients and healthy individuals, and comparing the blood protein profiles of the two, the biomarkers for early diagnosis and tissue traceability were identified to accurately establish an early diagnosis model for liver cancer and verify its efficacy.

Conditions

Interventions

DIAGNOSTIC_TEST

Proteomics

Proteomic is performed on all blood samples.

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Weilin Wang · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

  • Yuan Ding · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

  • Zhongquan Sun · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-05
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06544083 on ClinicalTrials.gov